The incidence of genital warts in Australian women prior to the national vaccination program

The quadrivalent human papillomavirus (HPV) vaccine currently being delivered to Australian women aged 12–26 years under the National HPV Vaccination Program promises to substantially reduce the incidence of genital warts. We review what is known about the burden of genital warts among Australian women. Incidence appears to peak among women aged 20–24 years, of whom 1.4% report genital warts in the previous year and who are hospitalised for treatment at a rate of 26 per 100 000. A surveillance system capable of documenting any decrease in the incidence of genital warts and recurrent respiratory papillomatosis after vaccination is urgently required.

Download Full-text

P5-S3.04 Continued decline in genital warts 3 years after introduction of quadrivalent Human papillomavirus (HPV) vaccination program

Sexually Transmitted Infections ◽

10.1136/sextrans-2011-050108.540 ◽

2011 ◽

Vol 87 (Suppl 1) ◽

pp. A321-A321

Author(s):

T. Read ◽

J. Hocking ◽

L. Gurrin ◽

M. Chen ◽

B. Donovan ◽

...

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccination ◽

Genital Warts ◽

Vaccination Program

Download Full-text

Association between sexual mixing and genital warts in heterosexual men in Australia: the herd protection from the female human papillomavirus vaccination program

Sexual Health ◽

10.1071/sh16053 ◽

2016 ◽

Vol 13 (5) ◽

pp. 489 ◽

Cited By ~ 4

Author(s):

Eric P. F. Chow ◽

Christopher K. Fairley

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccination ◽

Health Centre ◽

Genital Warts ◽

Vaccination Program ◽

Heterosexual Men ◽

Heterosexual Couples ◽

Human Papillomavirus Vaccination ◽

Female Partners ◽

Herd Protection

Australian-born women aged ≤32 years were eligible for the free female human papillomavirus (HPV) vaccination program introduced in 2007. A total of 1165 heterosexual couples attending the Melbourne Sexual Health Centre between 2011 and 2014 were included in this analysis. Findings showed the odds of having penile warts was 0.52-fold lower among men who had a female partner aged ≤32 years compared with men who had a female partners aged >32 years. This suggests men would have received herd protection from their female partners and hence they are at lower risk of acquiring genital warts.

Download Full-text

18. Association Between State-level Voting Patterns and Prior Receipt of the HPV Vaccine, an Analysis Using Data from the Behavioral Risk Factor Surveillance System 2016 – 2018

Open Forum Infectious Diseases ◽

10.1093/ofid/ofaa439.063 ◽

2020 ◽

Vol 7 (Supplement_1) ◽

pp. S31-S32

Author(s):

Maria A Corcorran ◽

Ethan Valinetz ◽

Abir Hussein ◽

Alyson J Littman ◽

Stephen E Hawes

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccine ◽

Surveillance System ◽

Vaccine Coverage ◽

Strong Association ◽

Hpv Vaccination ◽

State Level ◽

Vaccine Uptake ◽

Behavioral Risk ◽

Pharyngeal Cancer

Abstract Background Human papillomavirus (HPV) is the main cause of cervical, anal and oro-pharyngeal cancer worldwide. The HPV vaccine can prevent over 90% of HPV-related malignancies but vaccination rates in the United State (US) vary significantly by region. In this study, we assessed whether state-level politics is associated with receipt of HPV vaccination in the US, and if the association is modified by sex and age. Methods This study analyzed data from the Center for Disease Control and Prevention’s (CDC) Behavioral Risk Factors Surveillance System (BRFSS) survey. Persons ages 18 to 36 years of age, who lived in 17 states that included the supplementary “Adult Human Papillomavirus (HPV)” module questionnaire in 2016, 2017 or 2018, were included. We compared self-reported receipt of HPV vaccination among persons living in Republican versus Democratic states, based on state electoral college votes in the 2016 US presidential election. Mantel-Haenszel stratified analysis was used to estimate prevalence ratios and to assess for effect modification and control for confounding. Results Overall, 36,334 survey respondents were included in the analysis, 22.7% of whom reported prior receipt of the HPV vaccine, 28.1% in Democratic states and 20.4% in Republican states. When adjusted for race, living in a Democratic state was associated with a higher prevalence of prior receipt of the HPV vaccine in comparison to living in a Republican state. This association was strongest for men less than 26 years of age (PR 1.77, 95% CI: 1.58, 1.98) but remained significant for men ages 26 – 36 years (PR 1.51, 95% CI: 1.24, 1.85), women less than 26 years of age (PR 1.20, 95% CI: 1.13, 1.27), and women ages 26 – 36 years (PR 1.69, 95% CI: 1.57, 1.83). Conclusion Overall HPV vaccine coverage was low in adults 18–36 years of age. The strong association between state-level voting patterns and prior receipt of the HPV vaccine suggests that HPV vaccine coverage is lower in Republican states when compared to Democratic states. Further public health efforts are needed to promote HPV vaccine uptake among young men and women, particularly in Republican voting states. Disclosures All Authors: No reported disclosures

Download Full-text

Opportunities to increase rates of human papillomavirus vaccination in the New South Wales school program through enhanced catch-up

Sexual Health ◽

10.1071/sh15132 ◽

2016 ◽

Vol 13 (6) ◽

pp. 536 ◽

Cited By ~ 5

Author(s):

Christine Staples ◽

Michelle Butler ◽

Jennifer Nguyen ◽

David N. Durrheim ◽

Patrick Cashman ◽

...

Keyword(s):

High School Students ◽

Human Papillomavirus ◽

Hpv Vaccine ◽

Vaccine Coverage ◽

Hpv Vaccination ◽

Vaccination Program ◽

Completion Rates ◽

School Program ◽

Human Papillomavirus Vaccination ◽

Catch Up

Background The National Human Papillomavirus (HPV) Vaccination Program provides HPV vaccine to high school students through school-based vaccination. We aimed to: 1) assess the vaccine completion rates achieved when general practice is used for completing doses missed at school; 2) estimate the extent of under-notification by general practices of vaccine doses administered; and 3) assess the reasons reported by parents of students for non-completion of HPV vaccination. Methods: A postal survey was conducted of parents and carers of students and identified, using school-program records, as incompletely vaccinated in a large regional area of northern NSW vaccinated during 2010. Information about additional HPV vaccine doses received or reasons for non-completion were sought. Responses were analysed and records cross-checked against the National HPV Vaccination Program Register. Results: Of 660 parents or carers contacted, 207 (31.4%) responded. We found: 1) completion rates increased, an additional 122/207 (45.2%) students had completed all three doses of HPV through their general practitioner (GP); 2) under-notification of GP doses to the National HPV Vaccination Program Register was an issue with only 5/165 (3.0%) reported; 3) the main reason for non-completion was being unaware of the opportunity to catch-up at a GP. Conclusions: Underreporting by GPs of HPV vaccine doses administered and failure to complete courses identifies two opportunities to increase HPV vaccine coverage. These could be addressed by extending provision of catch-up HPV doses in school and by developing practice software solutions for automatic notification of doses from GPs. Reasons given by parents for non-completion, mostly logistical barriers, indicate a high degree of acceptance of HPV vaccination.

Download Full-text

National survey of general practitioners' experience of delivering the National Human Papillomavirus Vaccination Program

Sexual Health ◽

10.1071/sh09135 ◽

2010 ◽

Vol 7 (3) ◽

pp. 291 ◽

Cited By ~ 20

Author(s):

Julia M. L. Brotherton ◽

Julie Leask ◽

Cath Jackson ◽

Kirsten McCaffery ◽

Lyndal J. Trevena

Keyword(s):

Human Papillomavirus ◽

General Practitioners ◽

Hpv Vaccine ◽

Cervical Screening ◽

Hpv Vaccination ◽

Vaccine Safety ◽

Population Based ◽

Vaccination Program ◽

Routine Practice ◽

Human Papillomavirus Vaccination

Background: Between 2007 and 2009, Australian general practitioners (GPs) were involved in implementing a population-based human papillomavirus (HPV) vaccination program. We investigated GPs’ experiences of delivering the HPV vaccine to women aged 18–26. Methods: We posted a survey to 1000 GPs. The survey was informed by 12 domains incorporating constructs from psychological theories that focus on individual and environmental barriers and facilitators to effective implementation of evidence-based practice by health professionals. Results: The response rate was 32%. The 298 vaccinating GPs were positive about HPV vaccine implementation as part of their professional role as a worthwhile initiative within existing general practice infrastructure. They had more negative views about some aspects of program organisation, such as the timelines and potential adverse impacts on cervical screening rates. Vaccine safety was not a key concern. Actual levels of knowledge about HPV were moderate (mean score 3.41 out of 6 (s.d. 0.99)) and contrasted with self-rated knowledge, which was high (93% perceived their knowledge to be adequate). Notably, there were unrealistic expectations about the likely reduction in Pap abnormalities due to vaccination, which is important to clarify to avoid loss of confidence in the vaccine when this reduction does not eventuate. Conclusions: Australian GPs viewed HPV vaccination of women aged 18–26 years as an integrated part of their routine practice, with positive attitudes regarding its benefits and achievability. GPs are well placed to implement mass immunisation programs as long as they are supported by effective and timely communication strategies and resources.

Download Full-text

Knowledge of human papillomavirus (HPV) and the HPV vaccine in a national sample of Australian men and women

Sexual Health ◽

10.1071/sh09150 ◽

2010 ◽

Vol 7 (3) ◽

pp. 299 ◽

Cited By ~ 26

Author(s):

Marian K. Pitts ◽

Wendy Heywood ◽

Richard Ryall ◽

Anthony M. Smith ◽

Julia M. Shelley ◽

...

Keyword(s):

Cervical Cancer ◽

Human Papillomavirus ◽

Hpv Vaccine ◽

Genital Warts ◽

National Sample ◽

Vaccination Program ◽

Men And Women ◽

Pap Tests ◽

Hpv Knowledge ◽

Abnormal Pap Tests

Background: Human papillomavirus (HPV) knowledge has rarely been investigated in the context of a national vaccination program. The present study investigated HPV knowledge after the introduction of a national HPV vaccination program in Australia using a national sample of men and women. Methods: Questions assessing HPV knowledge were part of a broader national study of health and relationships administered via a computer-assisted telephone interview. These findings are from wave four of the study, conducted between 2007 and 2008. Knowledge questions about HPV included its association with cervical cancer, genital warts and abnormal Pap tests. Results: A total of 2634 women and 2556 men between the ages of 18 and 70 were interviewed. Overall, 62.8% (95% confidence interval (CI): 60.8–64.7%) of women and 38.3% (95% CI: 36.3–40.4%) of men had heard of HPV. Of these, 66.0% (95% CI: 64.1–67.9%) correctly answered that HPV is associated with cervical cancer, 50.2% (95% CI: 48.2–52.1%) answered that HPV is associated with abnormal Pap tests and 44.5% (95% CI: 42.5–46.5%) answered that HPV causes warts. Predictors of good knowledge included being female, aged between 26 and 45, holding higher education levels and older age at first sex. Ever having a Pap test was also associated with awareness about HPV. Conclusion: One of the highest levels of knowledge about HPV in Australia to date is reported in the present study. Knowledge about the association between HPV and cervical cancer was particularly high, especially when compared with knowledge of the association with genital warts. This appears to be a consequence of the marketing of the HPV vaccine as a vaccination against cervical cancer.

Download Full-text

Feasibility of a Coordinated Human Papillomavirus (HPV) Vaccination Program between a Medical Clinic and a Community Pharmacy

Pharmacy ◽

10.3390/pharmacy7030091 ◽

2019 ◽

Vol 7 (3) ◽

pp. 91 ◽

Cited By ~ 1

Author(s):

Doucette ◽

Kent ◽

Seegmiller ◽

McDonough ◽

Evans

Keyword(s):

Human Papillomavirus ◽

Community Pharmacy ◽

Hpv Vaccine ◽

Hpv Vaccination ◽

Initial Study ◽

Vaccination Program ◽

Medical Clinic ◽

Coordinated Care ◽

Medical Clinics ◽

To Receive

Human papillomavirus (HPV) vaccination coverage could be enhanced by community pharmacies working with medical clinics to coordinate completion of the HPV vaccination series. The objective for this study was to assess the feasibility of a coordinated model of HPV vaccine delivery in which a clinic gives the first dose and refers patients to a partnering community pharmacy to receive subsequent doses. A medical clinic-community pharmacy team was established in a Midwestern state to develop and operate a coordinated care model for HPV vaccinations. Under the coordinated model, the clinic identified patients needing HPV vaccination(s), administered the first dose and described the option to complete the vaccination series at the pharmacy. Interested patients then had an information sheet faxed and electronic prescriptions sent to the pharmacy. The pharmacy contacted the patients to schedule administration of 2nd and 3rd doses of the HPV vaccine. Over a 12-month period, 51 patients were referred to the pharmacy by the clinic. Of these, 23 patients received a total of 25 vaccinations. Clinic and pharmacy personnel mostly rated the coordinated program favorably. An initial study of a coordinated HPV vaccination program between a medical clinic and a community pharmacy supported patients getting HPV vaccinations.

Download Full-text

Human Papillomavirus Vaccination Rates of Military and Civilian Male Respondents to the Behavioral Risk Factors Surveillance System Between 2013 and 2015

Military Medicine ◽

10.1093/milmed/usy376 ◽

2019 ◽

Vol 184 (Supplement_1) ◽

pp. 121-125

Author(s):

Mary K Collins ◽

Christopher Tarney ◽

Eric R Craig ◽

Thomas Beltran ◽

Jasmine Han

Keyword(s):

Human Papillomavirus ◽

Hpv Vaccine ◽

Military Service ◽

Surveillance System ◽

Hpv Vaccination ◽

Behavioral Risk ◽

Weighted Estimate ◽

Cross Sectional ◽

Vaccination Rates ◽

The Usa

Abstract Objective To evaluate human papillomavirus (HPV) vaccination rates among men in the USA and to compare vaccination rates among men who had served in the military to those reporting no previous military service. Methods We performed a cross-sectional analysis using Behavioral Risk Factor Surveillance System (BRFSS) data from the 2013 to 2015 to analyze HPV vaccination rates for vaccine eligible adult men. The BRFSS is a multistage, cross-sectional telephone survey conducted nationally by state health departments. Univariable and logistic regression analyses were performed to examine the relationship between military service and HPV vaccination status was assessed as well as the number of HPV vaccination doses received. Results A total of 5,274 participants were analyzed representing a weighted estimate of 1.5 million HPV vaccine eligible men in the USA. The vaccination rate among veterans was 25.3% (95% confidence interval (CI), 18.8–33.3%) compared to 15.9% (95% CI, 14.3–17.6%) for civilians (p < 0.01). Veterans were more likely to report having received at least one dose of the HPV vaccine compared to civilian men (adjusted odds ratios [aOR] = 2.7, 95% CI, 1.7%-4.1%, p < 0.001). Conclusions Veteran men are more likely to have received HPV vaccination than similarly aged civilian men. However, for both civilians and veterans, the HPV vaccination coverage remains low when compared to their female counterparts.

Download Full-text